Previous close | 4.6000 |
Open | 4.6000 |
Bid | 0.1500 |
Ask | 4.7000 |
Strike | 470.00 |
Expiry date | 2022-10-21 |
Day's range | 6.5000 - 7.0000 |
Contract range | N/A |
Volume | |
Open interest | 12 |
Designed to thrive in challenging economic conditions, these companies are great buys during a downturn.
Every investor in IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) should be aware of the most powerful shareholder groups...
Participating in the call this morning are Jay Mazelsky, president and chief executive officer; Brian McKeon, chief financial officer; and John Ravis, vice president, investor relations. IDEXX would like to preface the discussion today with a caution regarding forward-looking statements.